Experts from the East European pharma & life science industry met at the Gerresheimer Pharma Day in Moscow

Prestigious internal and external speakers:lively discussions confirmed the value of advanced information provision

In the Russian capital numerous experts from the pharma & life science industry gathered at a very special event: for their East European customers the Gerresheimer Group organized the ‘Gerresheimer Pharma Day Moscow’ on September 23 and 24, 2009. In ten specialist talks the advanced program provided background knowledge about pharmaceutical primary packaging and drug delivery systems from various viewpoints. Across the field of glass and plastic the focus was on future-oriented production technologies for ampoules and vials as well as the filling of sterile syringes, specific requirements for primary packaging materials for biopharmaceutics and the application of eye drops.

At the two-day lecture event in the Moscow World Trade Center, Gerresheimer CEO Dr. Max Raster welcomed guests representing practically all pharmaceutical fields at a high level. The program was appropriately varied: the host company Gerresheimer - which itself enjoys a worldwide reputation as a leading innovative specialist in this sector and also ranks among the top addresses in Russia and Eastern Europe - covered the entire portfolio for pharma packaging.

With a wide product spectrum based on glass and plastic, Gerresheimer is furthermore one of the complete service providers for the pharma industry, with cross-system competence. For the exclusive highlight event in Moscow, Gerresheimer lined up in addition to its own internal internationally respected specialists a number of prestigious external speakers. The latter included a Russian expert: Shcherbinina Galina, Quality Control Manager for the Moscow pharma manufacturer Petrovax. She reported on positive experiences with the use of Gerresheimer RTF® syringe systems for vaccines in large-scale technological operations. It was with a contract for such systems, which are delivered to Petrovax siliconised, pre-assembled, sterilized and therefore completely ready to fill, that Gerresheimer entered the syringe business in the Russian pharma market in 2006.

Already in March this year the Group had organized a Gerresheimer Pharma Day in Bünde und Halle (Westphalia/Germany) for a highcaliber international audience. Here and again in Moscow, syringe systems and other glass products formed a particularly broad area of thematic focus which was handled from a wide variety of technological and scientific viewpoints ranging from tubular glass production through to specific forming, surface treatment and siliconisation. At the end of the event, Dr. Markus Piduhn, responsible in Gerresheimer’s Tubular Glass Division for the entire converting business in Europe and Asia, took leave of a highly satisfied audience: “I am sure we will be continuing and further intensifying this sort of information event.”

The Pharma Day is also assessed as a complete success by Burkhard Lingenberg, Director of Marketing and Communication for the Gerresheimer Group. Following the extremely positive feedback from the event in Spring, Moscow has confirmed the concept once again, he says: “The interest in the widely varied lectures and the lively discussions and conversations about them highlight how valuable such know-how transfer is for further development in our highly specialized fields. We will continue this path – with repeated new and topical subject areas.”*

More information about Pharma Day Moscow can be found under www.gerresheimer.de.

Contact Burkhard Lingenberg Director Corporate Communication & Marketing Telephone +49 211 6181-250 Telefax +49 211 6181-241 e-mail b.lingenberg@gerresheimer.com

Gerresheimer employs around 10,000 people in more than 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totalled €1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterised by high technical and regulatory barriers.